Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis.
Josef S
JS
Smolen
Maarten
M
Boers
Eric C
EC
Abadie
Ferdinand C
FC
Breedveld
Paul
P
Emery
Thomas
T
Bardin
Niti
N
Goel
Dominique J
DJ
Ethgen
Bernard P
BP
Avouac
Patrick
P
Durez
Bruno
B
Flamion
Andrea
A
Laslop
Pierre
P
Miossec
Susanne
S
Reiter
Jean-Yves
JY
Reginster
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D032921:Consensus; D035061:Control Groups; D017277:Drug Approval / Q000379:methods*; D004335:Drug and Narcotic Control; D015507:Drugs, Investigational; D005060:Europe; D006801:Humans
D018501:Antirheumatic Agents; D015507:Drugs, Investigational